BLCM — Bellicum Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.95m
- -$4.96m
- $1.50m
NASDAQ RESUMED AT 02:46 PM
NASDAQ RESUMED AT 02:41 PM
NASDAQ RESUMED AT 02:36 PM
NASDAQ RESUMED AT 02:29 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:23 PM
Brief: Bellicum Reports Q4 Revenue Of $5.1 Mln
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:34 AM
Brief: Bellicum Presents New Translational Data For BPX-601 at ASCO GI Cancers Symposium
Bellicum Pharma: Gains on $15 mln sale plan for manufacturing plant
Brief: Bellicum Pharmaceuticals Says Entered Into First Amendment To Loan & Security Agreement
Brief: Bellicum Pharmaceuticals Licenses Its CaspaCIDe Safety Switch To MD Anderson
Brief: Bellicum Pharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.68
Brief: Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Armistice Capital LLC Reports 6.5% Passive Stake In Bellicum Pharmaceuticals As Of August 16
Brief: Bellicum prices preferred stock & warrants offering at $100 per preferred stock and warrant
Brief: Bellicum Pharmaceuticals Announces Proposed $53 Mln Public Offering Of Preferred Stock And Warrants With Concurrent Private Placement
Brief: Bellicum Pharmaceuticals Reports Q2 2019 Results
Brief: Bellicum Pharmaceuticals Inc Files For Mixed Shelf Of Upto $400 Million
U.S. STOCKS ON THE MOVE-Apple, Symantec, F5 Networks, Cardinal Health